Can a common supplement boost muscle health? cleveland clinic investigates
NCT ID NCT05025865
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial at the Cleveland Clinic is studying how a specific type of hyaluronic acid (HA35) affects muscle protein in 24 healthy adults. Participants take either HA35 or a placebo capsule for three days, then undergo tests including muscle biopsies and a gut permeability test. The goal is to understand the basic mechanisms, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sodium hyaluronate (HA35)
- What this could lead to
- If successful, this could help scientists understand how HA35 affects muscle health, possibly pointing toward future treatments for muscle loss.
- What could go wrong
- This is a very early, small study in healthy people, not patients. It only tests short-term effects and may not lead to any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY CONTROLS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mining mountains of data to outsmart diabetes complications
- Psilocybin without the trip: scientists hunt for a microdose that skips hallucinations
- Manitoba DNA hunt could revolutionize schizophrenia care
- Brain insulin study aims to uncover why antipsychotics cause weight gain
- Ketone drink may boost brain fuel in prediabetes
- Experimental drug VVZ-2471 gets first safety check in humans